Trial · NCT02786719
Adverse events17
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 17 of 17
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ALT increased | Hepatobiliary disorders | High Risk Neuroblastoma Patients | 1 | 12 | 1 |
| other | Alk phos increased | Hepatobiliary disorders | High Risk Neuroblastoma Patients | 1 | 12 | 1 |
| other | Anemia | Blood and lymphatic system disorders | High Risk Neuroblastoma Patients | 12 | 12 | 73 |
| other | AST increased | Hepatobiliary disorders | High Risk Neuroblastoma Patients | 1 | 12 | 1 |
| other | Neutropenia | Blood and lymphatic system disorders | High Risk Neuroblastoma Patients | 12 | 12 | 100 |
| other | Pain | Musculoskeletal and connective tissue disorders | High Risk Neuroblastoma Patients | 2 | 12 | 2 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | High Risk Neuroblastoma Patients | 12 | 12 | 93 |
| other | Pleural effusion | Respiratory, thoracic and mediastinal disorders | High Risk Neuroblastoma Patients | 1 | 12 | 1 |
| other | Rash | Skin and subcutaneous tissue disorders | High Risk Neuroblastoma Patients | 1 | 12 | 1 |
| other | Weight loss | General disorders | High Risk Neuroblastoma Patients | 1 | 12 | 1 |
| other | WBC decreased | Blood and lymphatic system disorders | High Risk Neuroblastoma Patients | 12 | 12 | 119 |
| serious | Febrile Neutropenia | Blood and lymphatic system disorders | High Risk Neuroblastoma Patients | 9 | 12 | |
| serious | bacteremia | Infections and infestations | High Risk Neuroblastoma Patients | 4 | 12 | |
| serious | Skin/soft tissue infection | Infections and infestations | High Risk Neuroblastoma Patients | 3 | 12 | |
| serious | Urinary tract infection | Infections and infestations | High Risk Neuroblastoma Patients | 2 | 12 | |
| serious | Respiratory failure | Respiratory, thoracic and mediastinal disorders | High Risk Neuroblastoma Patients | 1 | 12 | |
| serious | Sinusoidal obstruction syndrome | Hepatobiliary disorders | High Risk Neuroblastoma Patients | 1 | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02786719/events